data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Kamada
(NASDAQ:KMDA)
4.61
0.11[2.44%]
At close: Jun 24
4.50
-0.1100[-2.39%]
After Hours: 4:01PM EDT
Day High/Low4.55 - 4.61
52 Week High/Low4.22 - 6.96
Open / Close4.56 / 4.61
Float / Outstanding29.1M / 44.8M
Vol / Avg.10.6K / 17.1K
Mkt Cap206.5M
P/E-
50d Avg. Price4.85
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float29.1M

Kamada (NASDAQ:KMDA), Quotes and News Summary

Kamada (NASDAQ: KMDA)

Day High/Low4.55 - 4.61
52 Week High/Low4.22 - 6.96
Open / Close4.56 / 4.61
Float / Outstanding29.1M / 44.8M
Vol / Avg.10.6K / 17.1K
Mkt Cap206.5M
P/E-
50d Avg. Price4.85
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float29.1M
Benzinga - Jun 1, 2022, 7:08AM
Benzinga - May 17, 2022, 7:10AM
Benzinga - May 17, 2022, 7:09AM
Benzinga - May 17, 2022, 7:09AM
Benzinga - Mar 15, 2022, 7:04AM
Benzinga - Mar 15, 2022, 7:03AM
Benzinga - Mar 3, 2022, 7:45AM
Benzinga - Nov 22, 2021, 10:44AM
Benzinga - Nov 22, 2021, 7:18AM
Benzinga - Nov 22, 2021, 7:01AM
Benzinga - Nov 22, 2021, 7:01AM
Benzinga - Aug 11, 2021, 7:12AM
Benzinga - Aug 11, 2021, 7:11AM
load more
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS0.020-0.040 -0.0600
REV25.630M28.093M2.463M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Kamada Questions & Answers

Q
How do I buy Kamada (KMDA) stock?
A

You can purchase shares of Kamada (NASDAQ: KMDA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Kamada's (KMDA) competitors?
A

There are no as such competitors for Kamada.

Q
What is the target price for Kamada (KMDA) stock?
A

The latest price target for Kamada (NASDAQ: KMDA) was reported by Chardan Capital on Friday, February 2, 2018. The analyst firm set a price target for 7.00 expecting KMDA to rise to within 12 months (a possible 51.84% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Kamada (KMDA)?
A

The stock price for Kamada (NASDAQ: KMDA) is $4.61 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Kamada (KMDA) pay a dividend?
A

There are no upcoming dividends for Kamada.

Q
When is Kamada (NASDAQ:KMDA) reporting earnings?
A

Kamada’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is Kamada (KMDA) going to split?
A

There is no upcoming split for Kamada.

Q
What sector and industry does Kamada (KMDA) operate in?
A

Kamada is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.